"There's been a surge of new data related to genomics and proteins," says Varshney. "We believe our computing resources at UMIACS can help our colleagues in Baltimore identify specific disease markers to address serious health concerns like cancer, diabetes or autism."
The new center will take full advantage of recent discoveries in science and technology. CHIB will benefit from significant advances in computing power over the past decade, including the development of multicore systems and cloud computing, as well as new methods of organizing, visualizing and analyzing massive amounts of data derived from high-throughput laboratory systems.
Using these approaches, CHIB will play a central role in facilitating genomic research, medical information management and translational science development.
"The School of Medicine and Institute of Genome Sciences bring together multidisciplinary teams of researchers who are taking cutting-edge research and translating this knowledge into diagnostics, vaccines and therapeutics," says UMB's White.
Researchers say the wealth of patient data available at Baltimore's medical school allows an unprecedented opportunity to link basic biological data and clinical concepts that can be used to improve diagnostic efforts and patient care.
The CHIB branch at College Park, housed within UMIACS, is supported by almost $1 million in seed funding from the provost's office, the Division of Research and colleges and schools whose research faculty are involved. A similar funding mechanism at UMB will support efforts in Baltimore.
"The new center strengthens our mission of using a truly m
|Contact: Ellen Ternes|
University of Maryland